Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Transplantation and Cellular Therapy|March 15, 2021
Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic TransplantationN Bejanyan, I Vlasova-St Louis, H Mohei, et al.
Bone Marrow Transplantation|May 24, 2011
Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donorsN S Majhail, C G Brunstein, R Shanley, et al.
Bone Marrow Transplantation|June 9, 2016
Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioningR Phelan, E Mann, C Napurski, et al.
Leukemia & Lymphoma|October 1, 1996
Unrelated donor bone marrow transplantation for hematological malignancies-current statusS M Davies, J E Wagner, D J Weisdorf, et al.
Experimental Hematology|March 1, 1988
Separation of rat bone marrow cells by counterflow centrifugal elutriation: a model for studying the effects of lymphocyte depletionJ E Wagner, A D Donnenberg, S J Noga, et al.
Blood|August 1, 1996
Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host diseaseJ E Wagner, J Rosenthal, R Sweetman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cellsJ J Gregory, J E Wagner, P C Verlander, et al.
Atmospheric Research|September 29, 2015
Investigation of the 3-D actinic flux field in mountainous terrainJ E Wagner, F Angelini, M Blumthaler, et al.
Blood|April 1, 1992
Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftmentJ E Wagner, H E Broxmeyer, R L Byrd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefitsJ E Wagner, M Zahurak, S Piantadosi, et al.
Pageof 17